Showing results (571-580 of 946) with videos related to
Sort By:
Pageof 95
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 9, 1998
Production and absorption of nitric oxide gas in the noseA B Dubois, J S Douglas, J T Stitt, et al.Neurology|May 9, 2001
Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's diseaseS Descombes, A M Bonnet, U E Gasser, et al.BMJ (Clinical Research Ed.)|March 5, 1999
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trialM Rösler, R Anand, A Cicin-Sain, et al.Journal of Medical Genetics|August 27, 1998
De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study GroupC Dumanchin, A Brice, D Campion, et al.Hormone Research|January 1, 1989
Somatostatin receptors in brain and pituitaryJ Epelbaum, F Agid, Y Agid, et al.Neuroscience Letters|December 23, 2009
Influence of sensory inputs and motor demands on the control of the centre of mass velocity during gait initiation in humansN Chastan, G W M Westby, S Tézenas du Montcel, et al.Neuroscience Letters|July 9, 1993
In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levelsM T Herrero, M Ruberg, E C Hirsch, et al.Neurology|November 26, 2003
Screening for DJ-1 mutations in early onset autosomal recessive parkinsonismP Ibáñez, G De Michele, V Bonifati, et al.Brain Research|October 3, 1994
Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiographyS Lehéricy, J P Brandel, E C Hirsch, et al.Neurology|February 1, 1981
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical ameliorationG Tell, P Böhlen, P J Schechter, et al.Pageof 95